» Articles » PMID: 39215188

Cytidine Deaminase-dependent Mitochondrial Biogenesis As a Potential Vulnerability in Pancreatic Cancer Cells

Abstract

Cytidine deaminase (CDA) converts cytidine and deoxycytidine into uridine and deoxyuridine as part of the pyrimidine salvage pathway. Elevated levels of CDA are found in pancreatic tumors and associated with chemoresistance. Recent evidence suggests that CDA has additional functions in cancer cell biology. In this work, we uncover a novel role of CDA in pancreatic cancer cell metabolism. CDA silencing impairs mitochondrial metabolite production, respiration, and ATP production in pancreatic cancer cells, leading to a so-called Pasteur effect metabolic shift towards glycolysis. Conversely, we find that CDA expression promotes mitochondrial biogenesis and oxidative phosphorylation, independently of CDA deaminase activity. Furthermore, we observe that patient primary cells overexpressing CDA are more sensitive to mitochondria-targeting drugs. Collectively, this work shows that CDA plays a non-canonical role in pancreatic cancer biology by promoting mitochondrial function, which could be translated into novel therapeutic vulnerabilities.

Citing Articles

MAT2a and AHCY inhibition disrupts antioxidant metabolism and reduces glioblastoma cell survival.

Rowland E, DAntuono M, Jermakowicz A, Ayad N bioRxiv. 2024; .

PMID: 39605416 PMC: 11601785. DOI: 10.1101/2024.11.23.624981.

References
1.
Hosein A, Dougan S, Aguirre A, Maitra A . Translational advances in pancreatic ductal adenocarcinoma therapy. Nat Cancer. 2022; 3(3):272-286. DOI: 10.1038/s43018-022-00349-2. View

2.
Rajeshkumar N, Yabuuchi S, Pai S, de Oliveira E, Kamphorst J, Rabinowitz J . Treatment of Pancreatic Cancer Patient-Derived Xenograft Panel with Metabolic Inhibitors Reveals Efficacy of Phenformin. Clin Cancer Res. 2017; 23(18):5639-5647. PMC: 6540110. DOI: 10.1158/1078-0432.CCR-17-1115. View

3.
Frances A, Cordelier P . The Emerging Role of Cytidine Deaminase in Human Diseases: A New Opportunity for Therapy?. Mol Ther. 2019; 28(2):357-366. PMC: 7001087. DOI: 10.1016/j.ymthe.2019.11.026. View

4.
Lumeau A, Bery N, Frances A, Gayral M, Labrousse G, Ribeyre C . Cytidine Deaminase Resolves Replicative Stress and Protects Pancreatic Cancer from DNA-Targeting Drugs. Cancer Res. 2024; 84(7):1013-1028. PMC: 10982645. DOI: 10.1158/0008-5472.CAN-22-3219. View

5.
Siegel R, Miller K, Wagle N, Jemal A . Cancer statistics, 2023. CA Cancer J Clin. 2023; 73(1):17-48. DOI: 10.3322/caac.21763. View